iBio (IBIO) Accounts Payables (2011 - 2026)

iBio (IBIO) has 16 years of Accounts Payables data on file, last reported at $3.0 million in Q1 2026.

• On a quarterly basis, Accounts Payables rose 105.48% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a 105.48% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 511.17% from the prior year.
• Accounts Payables for Q1 2026 stood at $3.0 million, up from $2.7 million in the prior quarter.
• Over the last five years, Accounts Payables for IBIO reached as high as $5.3 million in Q1 2022 and fell as low as $358000.0 in Q2 2024.
• Historically, Accounts Payables has averaged $2.4 million across 5 years, with a median of $2.0 million in 2023.
• Across the five-year window, Accounts Payables slumped 80.64% in 2024 and surged 511.17% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $4.0 million in 2022, then sank by 53.55% to $1.9 million in 2023, then tumbled by 66.97% to $614000.0 in 2024, then jumped by 332.25% to $2.7 million in 2025, then climbed by 14.36% to $3.0 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $3.0 million in Q1 2026, $2.7 million in Q4 2025, and $2.8 million in Q3 2025.